Casodex and Hepatic lesion - a phase IV clinical study of FDA data

Summary:

Hepatic lesion is reported as a side effect among people who take Casodex (bicalutamide), especially for people who are male, 60+ old, also take Zometa, and have Prostate cancer metastatic.

The phase IV clinical study analyzes which people have Hepatic lesion when taking Casodex. It is created by eHealthMe based on reports of 10,594 people who have side effects when taking Casodex from the FDA, and is updated regularly.

What is Casodex?

Casodex has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 10,725 Casodex users. Check the latest studies of Casodex.

What is Hepatic lesion?

Hepatic lesion is found to be associated with 673 drugs and 622 conditions by eHealthMe. Check the latest studies of Hepatic lesion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

10,594 people reported to have side effects when taking Casodex.
Among them, 22 people (0.21%) have Hepatic lesion.

Among these 22 people:

What is the gender of people who have Hepatic lesion when taking Casodex? *

female: 9.52 %
male: 90.48 %

What is the age of people who have Hepatic lesion when taking Casodex? *

What are other drugs people take besides Casodex? *

What are other side effects people have besides Hepatic lesion? *

Metastases To Bone (cancer spreads to bone): 15 people, 68.18%
Pain: 15 people, 68.18%
Stress And Anxiety: 14 people, 63.64%
Osteonecrosis Of Jaw (death of bone of jaw): 14 people, 63.64%
Prostatic Specific Antigen Increased: 13 people, 59.09%
Injury: 13 people, 59.09%
Weight Decreased: 13 people, 59.09%
Dizziness: 13 people, 59.09%
Tooth Loss: 12 people, 54.55%
Bone Pain: 12 people, 54.55%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 10 people, 45.45%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 36.36%
Asthma: 8 people, 36.36%
Bone Neoplasm Malignant (cancer of bone): 7 people, 31.82%
Metastases To Bone (cancer spreads to bone): 2 people, 9.09%
Constipation: 2 people, 9.09%
Bone Loss: 2 people, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.55%
Procedural Vomiting: 1 person, 4.55%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Casodex and have Hepatic lesion?

- Check whether Hepatic lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Casodex:

Casodex (10,725 reports)

Hepatic lesion treatments and more:

Hepatic lesion (5,726 reports)

Browse all side effects of Casodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic lesion:

Hepatic lesion (673 drugs)

Browse all the conditions that are associated with Hepatic lesion:

Hepatic lesion (622 conditions)

Related publications that referenced our studies

Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide (the active ingredients of Casodex) and Casodex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.